| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.336 | 46.077 | 86.730 | 119.273 | 129.003 | 124.525 | 127.345 | 135.170 | 133.989 |
| Total Income - EUR | - | 1.336 | 46.077 | 86.735 | 119.280 | 129.017 | 124.533 | 146.787 | 135.185 | 134.007 |
| Total Expenses - EUR | - | 430 | 36.599 | 55.715 | 61.844 | 65.732 | 71.940 | 90.001 | 77.521 | 82.726 |
| Gross Profit/Loss - EUR | - | 906 | 9.479 | 31.020 | 57.436 | 63.285 | 52.594 | 56.787 | 57.664 | 51.281 |
| Net Profit/Loss - EUR | - | 866 | 9.018 | 30.153 | 56.243 | 62.088 | 51.498 | 55.348 | 56.515 | 47.743 |
| Employees | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Epimed Cm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 33.035 | 28.076 | 23.306 | 18.646 | 40.568 | 32.997 | 26.019 |
| Current Assets | - | 1.396 | 14.374 | 30.590 | 48.528 | 54.740 | 49.285 | 40.778 | 66.359 | 74.910 |
| Inventories | - | 0 | 65 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 6.129 | 1.719 | 15.462 | 6.616 | 8.086 | 2.433 | 9.704 | 8.142 |
| Cash | - | 1.396 | 8.179 | 28.871 | 33.066 | 48.125 | 41.199 | 38.345 | 56.655 | 66.768 |
| Shareholders Funds | - | 911 | 9.913 | 39.884 | 56.294 | 62.170 | 51.645 | 55.414 | 77.481 | 81.090 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 42 |
| Debts | - | 485 | 4.460 | 23.741 | 20.311 | 15.877 | 16.286 | 25.932 | 21.874 | 19.838 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Epimed Cm Srl